These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9130420)

  • 1. Oxidised low density lipoprotein, antioxidants and coronary atherosclerosis.
    Gambhir DS; Gambhir JK
    Indian Heart J; 1997; 49(1):19-22. PubMed ID: 9130420
    [No Abstract]   [Full Text] [Related]  

  • 2. Antioxidants and atherosclerotic heart disease.
    Diaz MN; Frei B; Vita JA; Keaney JF
    N Engl J Med; 1997 Aug; 337(6):408-16. PubMed ID: 9241131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipoproteins, antioxidants, and coronary cardiopathy].
    Guimarães AC
    Arq Bras Cardiol; 1995 Sep; 65(3):289-95. PubMed ID: 8579520
    [No Abstract]   [Full Text] [Related]  

  • 4. [New discoveries on atherosclerosis. LDL oxidation plays a central role].
    Nilsson J
    Lakartidningen; 1995 Oct; 92(40):3684-6, 3691. PubMed ID: 7564616
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of free radicals in coronary atherosclerosis].
    Puddu P
    G Ital Cardiol; 1998 Nov; 28(11):1200-6. PubMed ID: 9866796
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of lipid oxidation in the development of atherosclerosis].
    Ylä-Herttuala S; Salonen JT
    Duodecim; 1994; 110(17):1643-52. PubMed ID: 7497996
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical implications of increased low-density lipoprotein oxidation in patients with hypercholesterolemia.
    Stalenhoef AF
    Nutrition; 1994; 10(6):564-6. PubMed ID: 7703607
    [No Abstract]   [Full Text] [Related]  

  • 9. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL.
    Norata GD; Tonti L; Roma P; Catapano AL
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):297-305. PubMed ID: 12616810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training improves low-density lipoprotein oxidability in untrained subjects with coronary artery disease.
    Ziegler S; Schaller G; Mittermayer F; Pleiner J; Mihaly J; Niessner A; Richter B; Steiner-Boeker S; Penak M; Strasser B; Wolzt M
    Arch Phys Med Rehabil; 2006 Feb; 87(2):265-9. PubMed ID: 16442983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
    Li GX; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin E and coronary heart disease--why the lack of effect in large clinical trials?].
    Andersen JR
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1932-6. PubMed ID: 11488186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors.
    Krobot KJ; Yin DD; Alemao E; Steinhagen-Thiessen E
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):37-45. PubMed ID: 15703504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case 1: a patient with elevated low-density lipoprotein cholesterol.
    Friedewald VE; Gotto AM
    Am J Cardiol; 2000 Jan; 85(1):131. PubMed ID: 11078257
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein oxidation and coronary atherosclerosis.
    Ziedén B; Molgaard J; Olsson AG
    Lancet; 1992 Sep; 340(8821):727-8. PubMed ID: 1355822
    [No Abstract]   [Full Text] [Related]  

  • 19. Tetrahydrobiopterin inhibits copper-induced oxidation of low density lipoprotein.
    Sakuma S; Fujimoto Y; Gohda Y; Fujita T
    Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):397-406. PubMed ID: 11589366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized or native low-density lipoprotein cholesterol: which is more important in atherogenesis?
    Mehta JL
    J Am Coll Cardiol; 2006 Sep; 48(5):980-2. PubMed ID: 16949490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.